Tag : primary progressive multiple sclerosis

Neurology

Multiple Sclerosis Prodrome Holds Promise of Earlier Diagnosis

Newsemia
There is now no doubt that a prodromal phase of MS exists for several years before the first demyelinating event occurs, latest evidence shows. Medscape...
Neurology

NfL Blood Biomarker Captures Suboptimal Treatment Response in MS

Newsemia
Measuring levels of neurofilament light chain is an effective way of detecting disease activity and the need to optimize treatment in patients with multiple sclerosis,...
Neurology

In MS, Serious AEs More Common in Rituximab vs Ocrelizumab

Newsemia
Medscape Medical News Source link...
Neurology

Cardiovascular Risk Factors Linked to Brain Atrophy in MS

Newsemia
Even low levels of exposure to cardiovascular risk factors are important in MS and might affect brain volume loss, a new study suggests. Medscape Medical...
Neurology

FDA OKs Ofatumumab (Kesimpta) for Relapsing Forms of MS

Newsemia
The FDA has approved ofatumumab (Kesimpta) as the first self-administered, targeted B-cell therapy for adults with relapsing forms of multiple sclerosis. FDA Approvals Source link...
Neurology

More Evidence for Neurofilament Light Chain as MS Biomarker

Newsemia
Tracking sNfL levels over time corresponds to multiple sclerosis disease course in a longitudinal study, but use of the blood biomarker for individual prognosis remains...
Neurology

Pace of Multiple Sclerosis Progression May Be Slowing

Newsemia
The risk for reaching specific disability milestones in patients with multiple sclerosis has decreased over the past decade, a large cohort study from Sweden suggests....
Neurology

'Burning Debate' on McDonald Diagnostic Criteria in MS

Newsemia
New McDonald diagnostic criteria for multiple sclerosis were the focus of a debate here at the ECTRIMS 2018 congress that spilled over onto Twitter. Medscape...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World